These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18375116)

  • 1. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.
    Chiappetta G; Ferraro A; Vuttariello E; Monaco M; Galdiero F; De Simone V; Califano D; Pallante P; Botti G; Pezzullo L; Pierantoni GM; Santoro M; Fusco A
    Eur J Cancer; 2008 May; 44(7):1015-21. PubMed ID: 18375116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
    Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
    Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGA2 expression analysis in cytological and paraffin-embedded tissue specimens of thyroid tumors by relative quantitative RT-PCR.
    Jin L; Lloyd RV; Nassar A; Lappinga PJ; Sebo TJ; Swartz K; Seys AR; Erickson-Johnson MR; Roth CW; Evers BR; Oliveira AM; Zhang J
    Diagn Mol Pathol; 2011 Jun; 20(2):71-80. PubMed ID: 21532495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
    Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of high-mobility group proteins A1 and A2 represents a valid diagnostic marker in post-pubertal testicular germ cell tumours.
    Franco R; Esposito F; Fedele M; Liguori G; Pierantoni GM; Botti G; Tramontano D; Fusco A; Chieffi P
    J Pathol; 2008 Jan; 214(1):58-64. PubMed ID: 17935122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
    Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
    Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
    Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
    Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
    Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
    Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
    Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
    J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers?
    Letsas KP; Vartholomatos G; Tsepi C; Tsatsoulis A; Frangou-Lazaridis M
    Neoplasma; 2007; 54(1):57-62. PubMed ID: 17203893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
    Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
    Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of mucins 1-6 in papillary thyroid carcinoma: evidence for transformation-dependent post-translational modifications of MUC1 in situ.
    Magro G; Schiappacassi M; Perissinotto D; Corsaro A; Borghese C; Belfiore A; Colombatti A; Grasso S; Botti C; Bombardieri E; Perris R
    J Pathol; 2003 Jul; 200(3):357-69. PubMed ID: 12845632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules.
    Lappinga PJ; Kip NS; Jin L; Lloyd RV; Henry MR; Zhang J; Nassar A
    Cancer Cytopathol; 2010 Oct; 118(5):287-97. PubMed ID: 20597139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High periostin expression correlates with aggressiveness in papillary thyroid carcinomas.
    Puppin C; Fabbro D; Dima M; Di Loreto C; Puxeddu E; Filetti S; Russo D; Damante G
    J Endocrinol; 2008 May; 197(2):401-8. PubMed ID: 18434370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGA2 expression in a canine model of prostate cancer.
    Winkler S; Murua Escobar H; Meyer B; Simon D; Eberle N; Baumgartner W; Loeschke S; Nolte I; Bullerdiek J
    Cancer Genet Cytogenet; 2007 Sep; 177(2):98-102. PubMed ID: 17854662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
    Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
    Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular localization of autotaxin impacts on its biological functions in human thyroid carcinoma cells.
    Seifert A; Klonisch T; Wulfaenger J; Haag F; Dralle H; Langner J; Hoang-Vu C; Kehlen A
    Oncol Rep; 2008 Jun; 19(6):1485-91. PubMed ID: 18497954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.